ADAA's Board of Directors oversee the long-term strategic plan for ADAA, enabling the organization to advance its mission, vision and strategic objectives. The Board of Directors actively helps guide, support and oversee ADAA’s activities—setting long-term goals and priorities for the Association and monitors ADAA’s strategic direction, fiscal health as well as its financial, administrative, and personnel policies. 

ADAA's Board of Directors is comprised of distinguished researchers, clinicians, and psychiatrists from across the United States and Canada who contribute a broad range of experience in patient care, academics and research. ADAA could not serve the public and mental health professional community without the dedication and commitment of these volunteers, many of whom have demanding full-time careers outside of the work they do for ADAA. To accomplish these tasks, the board meets frequently, with special meetings of Board subgroups convened as necessary. 

ADAA is governed by Bylaws, most recently updated in 2018. The Bylaws allow for not  less than 13 and not more than 17 ADAA Board members, and up to five honorary Board Members. Board members can serve up to three two- year terms. The Bylaws detail the Board selection processes.

The Executive Committee (EC)  is comprised of the Board Chair (Luana Marques, PhD), the President Elect (Charles Nemeroff, MD, PhD), a Treasurer (Risa Weisberg, PhD), the Past President (Beth Salcedo, MD), and the Secretary, Scott Rauch, MD.

All EC members are members of the current ADAA Board and are elected by the Board. The President presides over all meetings of the board. 
 

ADAA Stands Against Racism

June 4, 2020

The Anxiety and Depression Association of America’s (ADAA) mission is more critical than ever. Since ADAA’s founding 40 years ago, we have been committed to ensuring that everyone who struggles with an anxiety disorder, depression or PTSD can obtain the resources they need to live healthier and more productive lives. 
 
Over the last few months, we have seen that many of our poorest neighborhoods and communities of color have suffered disproportionately from the spread of COVID-19. Many of these same marginalized communities are also grappling with economic uncertainty, and now with the recent killing of George Floyd following so many other killings of African Americans, with increased mental health issues. ADAA’s mental health experts understand that exposure to these pervasive racial traumas and stressors are detrimental to one’s mental health. We also know that many people of color who suffer from mental health issues also experience less access to care and services.  Read the full statement here.


ADAA Welcomes New Board President Luana Marques, PhD - January 1, 2020

ADAA is pleased to announce that Luana Marques, PhD has assumed the role of President of the ADAA Board of Directors (BOD) effective January 1, 2020. Dr. Marques will serve a two-year term. Dr. Marques succeeds Beth Salcedo, MD, who served as ADAA BOD President from 2017-2019. Dr. Salcedo will now serve as Immediate Past Board Chair. Read more. 

Current Board Members

LuanaMarques56_3_2.jpgLuana Marques, PhD
President
Harvard Medical School and Massachusetts General Hospital

 

 

Charles Nemeroff Head Shot 2016_2.jpgCharles Nemeroff, MD, PhD
President-Elect
ADAA Chief Medical Officer
Professor and Chair of Psychiatry
Director, Institute for Early Life Adversity Research
Dell Medical School, The University of Texas at Austin

 

Mary E. (Beth) Salcedo, MD 
Immediate Past President
The Ross Center 
 

 

 

Risa B. Weisberg, PhD 
Treasurer
VA Boston Healthcare System
Boston University School of Medicine

 


Sanjay Mathew_0.jpgSanjay Mathew, MD
Secretary
Professor of Psychiatry and Behavioral Sciences
Baylor College of Medicine
 

 

 

Ken Goodman, LCSW
Private Practice - Los Angeles, CA


 

 

Paul Holtzheimer, MD
Dartmouth-Hitchcock Medical Center
White River Junction VA Medical Center

 

 

 

Tanja Jovanovic, PhD
Professor, Psychiatry and Behavioral Neuroscience
Wayne State University

 

 

 

Scott Rauch 2017_1.jpgScott Rauch, MD
Harvard

 

 

 

Sheila Rauch, PhD
Emory University School of Medicine
Atlanta VA Medical Center

 

 

 

Helen Blair Simpson 2018 _0.jpgHelen Blair Simpson, MD, PhD
Columbia University Medical Center/New York State Psychiatric Institute

 

 

 

Stein-Murray2-sml_0.jpgMurray Stein, MD, MPH — ex officio
University of California, San Diego

 

 

 

 

M  — ex officio
Laureate Institute for Brain Research

 

 

 

Honorary Board Member

Michael Gleason
Chairman and Chief Executive Officer of Consumer Brands, LLC

Executive Committee

Luana Marques, PhD
President
Harvard Medical School and Massachusetts General Hospital

Mary E. (Beth) Salcedo, MD
Immediate Past President
The Ross Center for Anxiety & Related Disorders

Risa B. Weisberg, PhD 
Treasurer
VA Boston Healthcare System
Boston University School of Medicine

Sanjay Mathew
Secretary
Harvard Medical School

Past Board Presidents

Mary E. (Beth) Salcedo, MD
Immediate Past President
The Ross Center for Anxiety & Related Disorders
 

 

 

 

 

 

 

 



mark-pollack-psychiatry (1)_0.jpgMark H. Pollack, MD - Chairman, Department of Psychiatry, Rush University Medical Center

 

 

 

 

 

 

 

 

 

 

 

 


Tribute to Jerilyn Ross

 

 

 

 


Institute for Behavior and Health, Maryland